News | RIVM

Details of proposed European PFAS ban released

Today, the European Chemicals Agency (ECHA) published details of a proposed ban on the production, use, sale and import of some 10,000 per- and polyfluoroalkyl substances (PFAS).

New risk limits for 18 pesticides in surface water

Evidence suggests that existing standards for some of these substances do not sufficiently protect the ecosystem. For others, no standards exist yet or the existing standards are outdated. If these

COVID-19 vaccine uptake related to neighbourhood demographics

COVID-19 vaccine uptake was lower in neighbourhoods that had proportionately higher percentages of residents from a non-Western migration background and residents who were more likely to vote for right-wing Christian and right-wing conservative political parties.

iStock

RIVM and TNO describe impact of future developments on occupational health and safety

RIVM and the Netherlands Organisation for Applied Scientific Research (TNO) have investigated the potential impact of developments in the next 20 years on occupational health and safety. How will artificial intelligence affect safety at work?

iStock

Provisional figures on participation in the National Immunisation Programme

According to RIVM’s registration system, at least 90% of babies have been vaccinated against mumps, measles and rubella (MMR).

State Secretary Blokhuis: boys will also be vaccinated against HPV virus

The vaccine against the HPV human papillomavirus virus will also become available for boys.

A guide for the safe reuse of diaper and incontinence materials

RIVM has developed a step-by-step plan for the safe reuse of diapers and incontinence material. This plan provides recyclers and licensing authorities with tools to carry out a risk assessment.

New data on greenhouse gas and ammonia emissions

Greenhouse gas emissions have fallen slightly; ammonia emissions remain stable.

Humans themselves are the most important source of ESBL Antibiotic Resistance

Human to human transfer is the main source of ESBL (Extended Spectrum Beta-Lactamase) antibiotic resistance, according to researchers from the ESBLAT research consortium, of which RIVM is a member.

Medication may affect diagnostic tests

The use of medication may affect diagnostic tests. This may distort the results of those tests.